The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 13,701–13,800 of 31,469
Jia, S., Gao, Z., Yan, S., Chen, Y., Sun, C., Li, X., & Chen, K. (2016) · Molecules · doi:10.3390/molecules21040453 · Cited by 25
Hussein, S. M. O. M. A. (2014) · Journal of Nutrition & Food Sciences · doi:10.4172/2155-9600.1000332 · Cited by 24
Childhood obesity, thyroid function, and insulin resistance – is there a link? A longitudinal study
Santos, M. I., Limbert, C., Marquês, F., et al. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0319 · Cited by 24
Hypovitaminosis D and Associated Cardiometabolic Risk in Women with PCOS
Mishra, S. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/19407.7771 · Cited by 24
Bernsmeier, C., Dill, M. T., Provenzano, A., Makowska, Z., Krol, I., Muscogiuri, G., Semela, D., Tornillo, L., Marra, F., Heim, M. H., et al. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.75 · Cited by 24
Adipose and Circulating CCL18 Levels Associate With Metabolic Risk Factors in Women
Hogling, D. E., Petrus, P., Gao, H., Bäckdahl, J., Dahlman, I. A., Laurencikiene, J., Acosta, J. R., Ehrlund, A., Näslund, E. B., Kulyté, A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2390 · Cited by 24
Göbl, C. S., Ott, J., Bozkurt, L., Feichtinger, M., Rehmann, V., Cserjan, A., Heinisch, M., Steinbrecher, H., Kukurová, I. J., Klepochová, R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160571 · Cited by 24
St-Pierre, D. H., Martin, J., Shimizu, H., et al. (2016) · Peptides · doi:10.1016/j.peptides.2016.09.014 · Cited by 24
Pourhassan, M., Glüer, C.-C., Pick, P., Tigges, W. P., & Müller, M. J. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.189 · Cited by 26
Tsunoda, T., Yamada, M., Akiyama, T., Minami, T., Yoshii, T., Kondo, Y., Satoh, S., & Terauchi, Y. (2016) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2754w · Cited by 24
Straznicky, N. E., Grima, M. T., Sari, C. I., Lambert, É., Phillips, S. E., Eikelis, N., Mariani, J. A., Kobayashi, D., Hering, D., Dixon, J. B., et al. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00516 · Cited by 24
Ryu, R., Jeong, T., Kim, Y.-S., Choi, J., Cho, S.-J., Kwon, E., Jung, U. J., Ji, H.-S., Shin, D., & Choi, M. (2016) · Nutrients · doi:10.3390/nu8110734 · Cited by 24
Foster, S. R., Omoruyi, F. O., Bustamante, J. J., Alexander-Lindo, R. L., & Dilworth, L. (2016) · International Journal of Experimental Pathology · doi:10.1111/iep.12210 · Cited by 24
Asada, M., Morioka, T., Yamazaki, Y., Kakutani, Y., Kawarabayashi, R., Motoyama, K., Mori, K., Fukumoto, S., Shioi, A., Shoji, T., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/8624313 · Cited by 24
Comparison of Various Indices of Energy Metabolism in Recumbent and Healthy Dairy Cows
Guyot, H., Detilleux, J., Lebreton, P., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169716 · Cited by 24
Altered Regional Gray Matter Volume in Obese Men: A Structural MRI Study
Zhang, B., Xiao, T., Tian, D., Wang, J., Wang, Q., Yu, C., Li, C., & Wang, J. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.00125 · Cited by 24
Kang, D. R., Yadav, D., Koh, S. B., Kim, J., & Ahn, S. V. (2017) · Yonsei Medical Journal · doi:10.3349/ymj.2017.58.2.339 · Cited by 25
Takahashi, E., Unoki‐Kubota, H., Shimizu, Y., Okamura, T., Iwata, W., Kajio, H., Yamamoto‐Honda, R., Shiga, T., Yamashita, S., Tobe, K., et al. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12638 · Cited by 23
Muscle Attenuation Is Associated With Newly Developed Hypertension in Men of African Ancestry
Zhao, Q., Zmuda, J. M., Kuipers, A. L., Bunker, C. H., Patrick, A. L., Youk, A. O., & Miljkovic, I. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08415 · Cited by 24
Mechanisms for the anti-obesity actions of bofutsushosan in high-fat diet-fed obese mice
Kobayashi, S., Kawasaki, Y., Takahashi, T., Maeno, H., & Nomura, M. (2017) · Chinese Medicine · doi:10.1186/s13020-017-0129-x · Cited by 24
Abdel-Ghany, S. M., Sayed, A. A.-R., El-Deek, S. E. M., ElBadre, H. M., Dahpy, M. A., Saleh, M. A., Mohammed, H. S. E.-D., & Mustafa, M. H. (2017) · Gene · doi:10.1016/j.gene.2017.05.007 · Cited by 24
Kim, M. S., & Lee, D. (2017) · Journal of Korean Medical Science · doi:10.3346/jkms.2017.32.6.985 · Cited by 24
Serum apelin levels and metabolic risk markers in obese women
Zaki, M. E., Kamal, S., Ezzat, W. M., Hassan, N. A.-M., Yousef, W., Ryad, H., Mohamed, R., Youness, E. R., Basha, W. A., & Elhosary, Y. A. (2017) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2017.05.002 · Cited by 24
Lu, L. P., Wan, Y. P., Xun, P., Zhou, K., Chen, C., Cheng, S., Zhang, M. Z., Wu, C., Lin, W. W., Jiang, Y., et al. (2017) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12494 · Cited by 24
Resaland, G. K., Aadland, E., Nilsen, A. K. O., Bartholomew, J. B., Andersen, L. B., & Anderssen, S. A. (2017) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.12955 · Cited by 31
Olza, J., Rupérez, A. I., Gil‐Campos, M., Leis, R., Cañete, R., Tojo, R., Gil, Á., & Aguilera, C. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081690 · Cited by 27
Esfandyari, S., Bahadoran, Z., Mirmiran, P., Tohidi, M., & Azizi, F. (2017) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.16-95 · Cited by 24
Kim, S., Chang, Y., Sung, E., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.06.026 · Cited by 24
Zhu, H., Xu, H., Chen, R., Liu, S., Xia, Y., Fu, Y., Li, X., Qian, Y., Zou, J., Yi, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08930-x · Cited by 24
Vardar, S. A., Karaca, A., Güldiken, S., Palabıyık, O., Süt, N., & Demir, A. M. (2017) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2017.1369998 · Cited by 24
Nagai, H., Kaisho, T., Yokoyama, K., Asakawa, T., Fujita, H., Matsumiya, K., Noguchi, J., Tsuchimori, K., Nishizawa, N., Kanematsu‐Yamaki, Y., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14077 · Cited by 25
New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation
de Andrade, A. R. C. F., Bittencourt, P. L., Codés, L., Evangelista, M. A., Castro, A. O., Sorte, N. B., Godoy, C., Bastos, J., & Cotrim, H. P. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.5285 · Cited by 24
Webel, A. R., Perazzo, J. D., Longenecker, C. T., Jenkins, T. L., Sattar, A., Rodriguez, M., Schreiner, N., & Josephson, R. (2017) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000450 · Cited by 25
Elaidy, S. M., Hussain, M. A., & El-Kherbetawy, M. K. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2017-0533 · Cited by 24
Okekunle, A. P., Wu, X., Duan, W., Feng, R., Li, Y., & Sun, C. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.12.003 · Cited by 25
Vuković, R., Milenković, T., Stojan, G., Vuković, A., Mitrović, K., Todorovic, S., & Soldatović, I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189232 · Cited by 24
The impact of serum adropin and ischemia modified albumin levels based on BMI in PCOS
İnal, Z. Ö., Erdem, S. S., Gederet, Y. T., Duran, C., Küçükaydın, Z., Kurku, H., & Sakarya, D. K. (2015) · Endokrynologia Polska · doi:10.5603/ep.a2018.0002 · Cited by 24
Burghardt, K. J., Seyoum, B., Dass, S. E., Sanders, E., Mallisho, A., & Yi, Z. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2097 · Cited by 25
Suhett, L. G., Silveira, B. K. S., Filgueiras, M. D. S., Pelúzio, M. D. C. G., Hermsdorff, H. H. M., & de Novaes, J. F. (2018) · Public Health Nutrition · doi:10.1017/s136898001800023x · Cited by 23
Moschonis, G., Androutsos, O., Hulshof, T., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12678 · Cited by 24
Dirks, M. L., Stephens, F. B., Jackman, S. R., Gordo, J. G., Machin, D. J., Pulsford, R. M., van Loon, L. J. C., & Wall, B. T. (2018) · Experimental Physiology · doi:10.1113/ep086961 · Cited by 26
Dietary habits associated with reduced insulin resistance: The Nagahama study
Ikeda, K., Sato, T. S., Nakayama, T., Tanaka, D., Nagashima, K., Mano-Usui, F., Joo, E., Fujimoto, S., Takahashi, Y., Kosugi, S., et al. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.006 · Cited by 26
Skrede, T., Aadland, E., Andersen, L. B., Stavnsbo, M., Anderssen, S. A., Resaland, G. K., & Ekelund, U. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0108-z · Cited by 25
Dibai, D. B., Cabiddu, R., Mendes, R. G., Tossini, N. B., Arakelian, V. M., Caruso, F., Júnior, J. C. B., Arena, R. A., & Borghi‐Silva, A. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180105 · Cited by 25
Strizich, G., Kaplan, R. C., Sotres‐Alvarez, D., Diaz, K. M., Daigre, A. L., Carnethon, M. R., Vidot, D. C., Delamater, A. M., Perez, L. G., Perreira, K. M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00356 · Cited by 24
Resistance exercise stimulates mixed muscle protein synthesis in lean and obese young adults
Hulston, C. J., Woods, R. M., Dewhurst-Trigg, R., Parry, S. A., Gagnon, S., Baker, L. A., James, L. J., Markey, O., Martin, N. R. W., Ferguson, R. A., et al. (2018) · Physiological Reports · doi:10.14814/phy2.13799 · Cited by 24
Jahromi, B. N., Dabbaghmanesh, M. H., Bakhshaie, P., Parsanezhad, M. E., Anvar, Z., Alborzi, M., Zarei, A., & Bakhshaei, M. (2018) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2018.06.015 · Cited by 24
Song, Y., Miao, S., Li, Y., et al. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27396 · Cited by 24
Glucose metabolism in patients with psoriasis
Friis, N. U., Hoffmann, N., Gyldenløve, M., Skov, L., Vilsbøll, T., Knop, F. K., & Storgaard, H. (2018) · British Journal of Dermatology · doi:10.1111/bjd.17349 · Cited by 23
Kurstjens, S., de Baaij, J. H. F., Bos, C., van den Munckhof, I., Garzero, V., de Vries, M. A., Burggraaf, B., van Diepen, J. A., Riksen, N. P., Rutten, J. H. W., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4771-3 · Cited by 25
Gao, F., Zhang, Y., Ge, S., Lu, H., Chen, R., Fang, P., Shen, Y., Wang, C., & Jia, W. (2018) · Nutrition & Metabolism · doi:10.1186/s12986-018-0321-8 · Cited by 24
Ali, N., Mahmoud, A. A. A., Mahmoud, M. F., et al. (2019) · Drug and Chemical Toxicology · doi:10.1080/01480545.2018.1544984 · Cited by 24
Rodríguez, J. L. M., Gonzalez-Cantero, J., González‐Cantero, Á., Martí‐Bonmatí, L., Alberich‐Bayarri, Á., Cejudo, M. T. G., & Gonzalez-Calvin, J. L. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.01.005 · Cited by 24
Chen, X., Wang, H., Jiang, M., Zhao, J., Fan, C., Wang, Y., & Peng, W. (2018) · Europe PMC (PubMed Central) · Cited by 24
Mullally, J. A., Febres, G., Bessler, M., & Körner, J. (2019) · Scientific Reports · doi:10.1038/s41598-018-38283-y · Cited by 26
Emral, R., Aydoğan, B. İ., Köse, A. D., Demir, Ö., & Çorapçıoğlu, D. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2019.01.007 · Cited by 24
Naser, W., Adam, I., Rayis, D. A., Ahmed, M., & Hamdan, H. Z. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2429-x · Cited by 25
Adamska, A., Łebkowska, A., Krentowska, A., Adamski, M., & Kowalska, I. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00873 · Cited by 25
Association of Extracellular Vesicle Protein Cargo with Race and Clinical Markers of Mortality
Hooten, N. N., McFarland, M. H., Freeman, D. W., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-53640-1 · Cited by 24
Ghibu, S., Crăciun, E. C., Rusu, R., Morgovan, C., Mogoșan, C., Rochette, L., Adrian Florin, G. A. L., & Dronca, M. (2019) · Antioxidants · doi:10.3390/antiox8120636 · Cited by 25
Associations between Red Meat Intake and Sleep Parameters in Patients with Obstructive Sleep Apnea
Kechribari, I., Kontogianni, M. D., Georgoulis, M., Lamprou, K., Mourati, I., Vagiakis, E., & Yiannakouris, N. (2019) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2019.10.016 · Cited by 24
Exercise Training Adaptations in Metabolic Syndrome Individuals on Chronic Statin Treatment
Morales‐Palomo, F., Ramírez-Jiménez, M., ORTEGA, J. F., Moreno‐Cabañas, A., & Mora‐Rodríguez, R. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz304 · Cited by 24
Hetta, . F., Eldeen, M. E. E., Mohamed, G. A., Gaber, M. A., ElBadre, H. M., Ahmed, E. A., Abd-ellatief, R. B., El-Baky, R. M. A., Elkady, A., Nafee, A. M. A., et al. (2018) · PubMed · Cited by 24
Garcia-Ribera, S., Amat-Bou, M., Climent, E., Llobet, M., Chenoll, E., Corripio, R., Ibáñez, L., Ramon‐Krauel, M., & Lerín, C. (2020) · Nutrients · doi:10.3390/nu12041063 · Cited by 24
Extracellular vesicles and extracellular RNA in aging and age-related disease
Hooten, N. N. (2020) · Translational Medicine of Aging · doi:10.1016/j.tma.2020.07.006 · Cited by 24
Protective effect of fenofibrate against high‐fat–high‐fructose diet induced non‐obese NAFLD in rats
Abdelmoneim, D., El‐Adl, M., El‐Sayed, G., & Said, E. S. E. S. E. (2020) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12597 · Cited by 24
Tan, H. C., Hsu, J. W.-C., Kovalik, J., Eng, A. K. H., Chan, W. H., Khoo, C. M., Tai, E. S., Chacko, S. K., & Jahoor, F. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa298 · Cited by 25
Seesen, M., Lucchini, R. G., Siriruttanapruk, S., Sapbamrer, R., Hongsibsong, S., Woskie, S., & Kongtip, P. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17218140 · Cited by 27
Intestinal Dysbiosis Correlates With Sirolimus-induced Metabolic Disorders in Mice
Han, Y., Wu, L. M., Ling, Q., Wu, P., Zhang, C., Jia, L., Weng, H., & Wang, B. (2020) · Transplantation · doi:10.1097/tp.0000000000003494 · Cited by 26
Bima, A. I. H., Mahdi, A. S., Fayez, F. F. A., Khawaja, T. M., El‐khair, S. M. A., & Elsamanoudy, A. Z. (2021) · Cells · doi:10.3390/cells10040920 · Cited by 24
Prevalence and characteristics of metabolic syndrome in primary hyperparathyroidism.
Tassone, F., Gianotti, L., Baffoni, C., Cesario, F., Magro, G. G., Pellegrino, M., Emmolo, I., Maccario, M., & Borretta, G. (2012) · PubMed · doi:10.3275/8192 · Cited by 25
Fawzi, M. H., Fawzi, M. M., Said, N. S., Fawzi, M. M., Fouad, A. A., & Abdel-Moety, H. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.057 · Cited by 26
Tewari, R., Bhatti, J. S., Bhatti, G. K., Joshi, A., Rai, S., Mastana, S. S., Ralhan, S. K., & Bansal, D. D. (2007) · International Journal of Diabetes in Developing Countries · doi:10.4103/0973-3930.38629 · Cited by 24
Ji, B., Zhang, S.-H., Gong, L.-L., Wang, Z.-H., Ren, W., Li, Q.-F., & Li, R. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.01.011 · Cited by 26
Fernández-Martos, C. M., Moltó, E., Gallardo, N., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2008.09.014 · Cited by 24
Insulin Resistance, Hyperinsulinemia, and Energy Intake in Overweight Children
Han, J. C., Rutledge, M. S., Kozlosky, M., Salaita, C. G., Gustafson, J. K., Keil, M. F., Fleisch, A. F., Roberts, M. D., Ning, C., & Yanovski, J. A. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.12.036 · Cited by 24
Soro‐Paavonen, A., Westerbacka, J., Ehnholm, C., & Taskinen, M. (2006) · Annals of Medicine · doi:10.1080/07853890500526352 · Cited by 24
Shadoan, M. K., Kavanagh, K., Zhang, L., Anthony, M. S., & Wagner, J. D. (2007) · Metabolism · doi:10.1016/j.metabol.2007.01.014 · Cited by 25
Forbes, S., Godsland, I. F., Taylor-Robinson, S. D., Bell, J. D., Thomas, E. L., Patel, N., Hamilton, G., Parker, K. H., Marshall, I., Gray, C. D., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2956-3 · Cited by 25
Bosco, D., Costa, R., Plastino, M., Branca, D., Cotronei, P., Sperlì, T., Santacroce, N., Siniscalchi, A., Consoli, D., Ceccotti, C., et al. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.03.017 · Cited by 24
Idiopathic Hirsutism and Insulin Resistance
Talaei, A., Adgi, Z., & kelishadi, M. M. (2013) · International Journal of Endocrinology · doi:10.1155/2013/593197 · Cited by 23
Belfki, H., Ali, S. B., Bougatef, S., Ahmed, D. B., Haddad, N., Jmal, A., Abdennebi, M., & Romdhane, H. B. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2011.06.007 · Cited by 24
Otto, C., Otto, B., Göke, B., Pfeiffer, A. F. H., Lehrke, M., Vogeser, M., Spranger, J., & Parhofer, K. G. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03345545 · Cited by 24
Subclinical inflammation and soleus muscle intramyocellular lipids in healthy Asian Indian males
Sinha, S., Rathi, M., Misra, A., Kumar, V., Kumar, M., Jagannathan, N. R., Pandey, R. M., Dwivedi, M., & Luthra, K. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02353.x · Cited by 24
Sung, K., & Ryu, S. (2004) · Clinical and Experimental Hypertension · doi:10.1081/ceh-200031833 · Cited by 24
Effect of Smoking Habit on Circulating Adipokines in Diabetic and Non-Diabetic Subjects
Al-Mutairi, S., Mojiminiyi, O. A., Shihab‐Eldeen, A., Sharafi, A. A., & Abdella, N. (2008) · Annals of Nutrition and Metabolism · doi:10.1159/000151487 · Cited by 24
Rosenbaum, P., Peres, R. B., Zanella, M. T., & Ferreira, S. R. G. (2002) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2002000800004 · Cited by 24
Lemieux, C., Gélinas, Y., Lalonde, J., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400448-jlr200 · Cited by 24
Jia, D., Yamamoto, M., Otani, M., & Otsuki, M. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.006 · Cited by 24
Dias, I. B. F., Panazzolo, D. G., Marques, M. F., et al. (2013) · Clinical Endocrinology · doi:10.1111/cen.12195 · Cited by 24
Rodriguez, S., Gaunt, T. R., Dennison, E., Chen, X., Syddall, H., Phillips, D., Cooper, C., & Day, I. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201505 · Cited by 26
Somma, C. D., Angrisani, L., Rota, F., Savanelli, M. C., Cascella, T., Belfiore, A., Orio, F., Lombardi, G., Colao, A., & Savastano, S. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03183.x · Cited by 24
Insulin resistance and altered glucose transporter 4 expression in experimental uremia
Aksentijević, D., Bhandari, S., & Seymour, A. L. (2009) · Kidney International · doi:10.1038/ki.2008.691 · Cited by 25
Association of RBP4 Gene Variants and Serum HDL Cholesterol Levels in the Newfoundland Population
Shea, J. L., Loredo‐Osti, J. C., & Sun, G. (2009) · Obesity · doi:10.1038/oby.2009.398 · Cited by 24
Ågren, J. J., Hallikainen, M., Vidgren, H. M., Miettinen, T. A., & Gylling, H. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.11.006 · Cited by 24
Ramachandran, A., Snehalatha, C., Satyavani, K., Sivasankari, S., & Viswanathan, V. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.08.009 · Cited by 24
de Luis, D. A., Sagrado, M. G., Aller, R., Izaola, O., & Conde, R. (2007) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.04.019 · Cited by 24
Aypak, C., Türedi, Ö., Bircan, M. A., et al. (2013) · Platelets · doi:10.3109/09537104.2013.827783 · Cited by 24
Derosa, G., Gaddi, A., Ciccarelli, L., et al. (2005) · Journal of International Medical Research · doi:10.1177/147323000503300303 · Cited by 24
Raitakari, O. T., Rönnemaa, T., Huupponen, R., et al. (2007) · Diabetes Care · doi:10.2337/dc07-0539 · Cited by 24
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
